While the blood concentration of VEGF was similar between control healthy subjects and patients with cancer, blood concentrations of FGF-2 were significantly higher in patients with thyroid cancer compared with controls (29.52 ± 4.99 vs. 6.05 ± 1.43 pg/mL; p < 0.001). The gene discussed is VEGFA; the disease is cancer.